drugset / Trial / NCT04184466
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects
RandomizedCrossoverSingle-blindBasic science
Summary
Pharmacokinetics and pharmacodynamics study of 2 formulations of insulin aspart (Insulin Aspart GEROPHARM vers. NovoRapid® Penfill® Novo Nordisk)
Timeline
- Start
- 2018-10-18
- Primary completion
- 2018-12-19
- Completion
- 2018-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | 0.3 iu/kg | Subcutaneous |
Indications
No indication recorded.